STMicroelectronics STM reported second-quarter revenue of $3.49 billion, up 26% year over year and above the midpoint of guidance. ST forecasts third-quarter revenue of $3.70 billion, up 16% year over ...

'At that point, they arguably no longer need the government's retirement safety net' "I believe Medicaid - and perhaps even Medicare - should function primarily as catastrophic coverage rather than ...

If the FDA allows these seven peptides to be reclassified, that means compounding pharmacies can legally produce them A group of independent advisers to the FDA is meeting Thursday and Friday to vote ...

Ford Motor said Wednesday that it will integrate Apple Maps directly into its upcoming Universal Electric Vehicle platform beginning in 2027, as the automaker deepens its partnership with Apple to ...

I read your response to the letter about the man who passed away after receiving only one Social Security check ("'It's heartbreaking': My brother claimed Social Security at 70. He died from cancer ...

Provided by PR Newswire Jul 22, 2026, 8:15:00 PM ...

Tesla TSLA generated mixed second-quarter results as higher deliveries led to revenue growth, but increased expenses weighed on profits. Why it matters: Tesla’s adjusted earnings per share came in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The Food and Drug Administration is looking into a new outbreak of cyclospora linked to a not yet identified product and has initiated traceback. The new outbreak includes 72 cases. Government ...

The first half of 2026 brought good news for equity-income investors: The typical dividend-oriented strategy finally outperformed the US broad stock market. After trailing the S&P 500 in eight of the ...

Medalist Rating covers product that tracks indices created or licensed by Morningstar. See Disclosure for more details.

IBB Performance - Review the performance history of the iShares Biotechnology ETF to see it's current status, yearly returns, and dividend history.